Filing Details

Accession Number:
0001367644-21-000101
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-27 16:37:50
Reporting Period:
2021-05-25
Accepted Time:
2021-05-27 16:37:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1367644 Emergent Biosolutions Inc. EBS Pharmaceutical Preparations (2834) 141902018
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1685720 C Kathryn Zoon 400 Professional Drive
Gaithersburg MD 20879
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-05-25 3,139 $56.48 14,377 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.
  2. All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on February 25, 2021, that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act").
  3. The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $56.11 to $56.86.